Status:

RECRUITING

Alpha-synuclein Rt-quic and Neurologic Symptoms in Persons With idiOpathic anosMiA

Lead Sponsor:

Danish Dementia Research Centre

Collaborating Sponsors:

Danish Reference Center for Prion Diseases, Rigshospitalet

Department of Otorhinolaryngology, Head and Neck Surgery & Audiology, Rigshospitalet

Conditions:

Idiopathic Anosmia

Idiopathic Hyposmia

Eligibility:

All Genders

55-75 years

Brief Summary

Test of early warning signs and RT-QuIC in patients with idiopathic olfactory dysfunction

Detailed Description

Background. The number of persons living with dementia is increasing in Denmark and worldwide because the population is generally growing older. Dementia with Lewy bodies (DLB) is the second most prev...

Eligibility Criteria

Inclusion criteria with patients iOD:

  • Age 55 -75 years of age
  • Slowly progressing and non-fluctuating iOD
  • Able to give informed consent and to cooperate as evaluated by the PI

Exclusion criteria with patients iOD:

  • Diagnosed with a neurodegenerative disease or major neurological/psychiatric condition.
  • Anosmia/hyposmia caused by sino-nasal disease (including chronic rhinitis and allergy), after trauma, infection, congenial, olfactory dysfunction due to surgery, or toxins/drugs affecting the olfactory function.
  • Olfactory dysfunction with response to systemic or local corticosteroids if tried
  • Severe nasal cavity abnormalities or infections.
  • Overt signs of dementia or PD
  • Current alcohol or drug abuse
  • Terminal illness
  • Diagnosed with neurodegenerative disease or major neurological/psychiatric condition.

Inclusion criteria controls:

  • Age 55 -75 years of age
  • Able to give informed consent
  • Able to cooperate as evaluated by the PI

Exclusion criteria controls:

  • Olfactory dysfunction on clinical test
  • Overt signs of dementia or PD
  • Severe nasal cavity abnormalities or infections.
  • Current alcohol or drug abuse
  • Diagnosed with neurodegenerative disease or major neurological/psychiatric condition.

Key Trial Info

Start Date :

February 1 2023

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 1 2032

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT05740683

Start Date

February 1 2023

End Date

December 1 2032

Last Update

October 2 2024

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Danish Dementia Research Centre

Copenhagen, Denmark, 2100

2

Oskar McWilliam

Copenhagen, Denmark, 2100